Dados B3Stocks › PFRM3 PT

Consumo Cíclico

PFRM3 — PROFARMA DISTRIB PROD FARMACEUTICOS S.A.

CNPJ 45.453.214/0001-51 · listed classes: PFRM3 · CVM code 20346

7.6P/E
0.7P/B
2.8EV/EBITDA
31.5%FCF yield
9.0%ROE 2025
15.8%ROIC 2025
P/E, P/B and EV/EBITDA priced at the session of 2026-03-27 (R$ 7.35), the first one after the 2025 filing became public on 2026-03-27 — point-in-time, not the 31 December price. acoes_escala_milhares

The full history, year by year

The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.

indicator2010201120122013201420152016201720182019202020212022202320242025
ROE 6.6%!5.0%7.4%3.6%-8.3%-3.1%-6.9%-15.0%-1.1%1.2%5.1%7.3%7.1%5.8%9.0%9.0%
ROIC 9.4%!8.4%9.1%8.1%1.3%!4.1%!4.8%!-0.6%!2.6%!2.4%7.8%!7.4%!12.7%!12.1%13.4%15.8%!
ROA 3.2%!2.4%3.2%1.2%-2.9%-1.0%-2.0%-4.2%-0.4%0.4%1.8%2.0%2.0%1.7%2.3%2.1%
Gross margin 5.8%4.9%5.4%8.9%12.5%12.6%15.3%17.1%15.9%15.4%13.9%14.2%14.7%14.9%15.0%15.3%
EBIT margin 2.2%1.9%2.2%2.2%0.6%1.7%1.9%-0.3%1.3%1.3%2.2%2.0%3.1%3.0%3.0%3.1%
Net margin 1.1%0.8%1.1%0.5%-1.5%-0.6%-1.2%-2.7%-0.2%0.2%1.1%1.2%1.1%0.9%1.2%1.1%
Revenue growth (1y) 5.9%14.6%7.3%-0.6%0.5%17.9%0.4%4.2%12.4%14.2%17.0%21.9%10.8%17.2%12.8%
Revenue growth (5y CAGR) 2.0%4.3%4.9%4.2%6.8%9.6%9.4%13.8%15.2%16.2%15.9%
Net debt/EBITDA 1.43x1.71x1.88x5.66x6.68x3.68x4.21x27.92x4.59x2.82x1.03x1.44x1.26x1.43x1.22x1.16x
Current ratio 2.32x2.23x1.88x1.82x1.72x1.38x1.46x1.04x1.38x1.33x1.61x1.50x1.52x1.45x1.34x1.29x

The current year, quarter by quarter

As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.

quarterrevenueprofitnet marginP/E TTMP/Bfiled on
2024T1!2,250.72.00.1%9.60.592024-05-08
2024T2!2,282.831.91.4%8.30.592024-08-07
2024T3!2,604.252.32.0%7.30.592024-10-30
2025T1!2,710.511.70.4%7.70.732025-05-05
2025T2!2,702.023.50.9%7.90.702025-07-30
2025T3!2,850.149.11.7%8.30.692025-10-29
2026T1!2,873.9-1.3-0.0%8.90.702026-05-06
2026T2!3,577.071.62.0%4.90.532026-07-29

Full series, every quarter: GET /empresas/PFRM3/trimestres

Dividends per year

yearper sharepayments
2025R$ 0.64433
2024R$ 0.57503
2023R$ 0.38582
2022R$ 0.17331
2021R$ 0.27061
2014R$ 0.13841
2013R$ 0.20451
2012R$ 0.13961

Piotroski F-Score 7/9 (2025) — what each criterion means.

Restated filings for this company

The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.

fiscal yearaccountfirst filingrestated
2012DRE 3.013,802.73,233.1
2012DRE 3.02-3,597.9-3,028.3
2013DRE 3.02-2,854.0-2,734.7
2013DRE 3.03231.2350.4
2024DFC_MI 6.01302.0326.7
2010BPP 2.03518.9508.4
2010DMPL 5.07518.9508.4
2010DMPL 5.03485.4478.2

This company appears in

Other companies in Consumer Cyclical

109 more with a page, same CVM sector — a classification of the regulator's, not ours.

Take this into your code

Everything on this page is also JSON: GET /empresas/PFRM3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).

Price coverage: 4,118 sessions, 2010-01-04 → 2026-09-04 · methodology · how we verify

Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 11:08 UTC. If this does not match /saude, you are reading a cached copy.